NewsIOI Loders Croklaan and Kerry Group to partner on Betapol®
02/04/2015, IOI Loders Croklaan |
|
|
[table=98%]
[tr][td][table=98%,transparent]
[tr][td][table=98%,transparent]
[tr][td][table=98%,transparent]
[tr][td] IOI Loders Croklaan and Kerry Group are pleased to announce that they have reached an agreement to form a joint venture company to develop and market the nutrition lipid Betapol® business. The parties expect to conclude agreements over the coming weeks subject to competition approval. The equal share partnership is centered around Betapol®, a specialty lipid for infant nutrition. The new partnership will be able to reach global markets more effectively, and will stimulate joint developments to extend the Betapol® portfolio for infant nutrition, and expand into other key nutrition market segments.
Kerry Group is a public food company headquartered in Ireland. It is quoted on the Dublin ISEQ and London stock exchanges.
Both partners will bring specific advantages and expertise to the joint venture: - IOI Loders Croklaan - the creator of Betapol®, and first to introduce OPO-type fats to the market - holds over 25 years of experience in the supply of specialty lipids to the infant nutrition market, and will continue to manufacture the Betapol® product range for the joint venture. Primary production is at its state of the art enzymatic facility in Pasir Gudang, Malaysia with additional blending capability in Wormerveer, The Netherlands. IOI Loders Croklaan will continue to manage all product logistics, and will further build upon its commitment to create a traceable and sustainable supply chain.
- Kerry has over 30 years’ experience as a trusted partner to the nutrition market, with dedicated commercial and nutritional science teams delivering a broad portfolio of scientifically based nutritional products for all consumer life stages. Kerry’s
|